This company listing is no longer active
0HB Stock Overview
Spectral AI, Inc. operates as an artificial intelligence (AI) company.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Spectral AI, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.57 |
| 52 Week High | €0.63 |
| 52 Week Low | €0.25 |
| Beta | -0.057 |
| 1 Month Change | 15.85% |
| 3 Month Change | 33.18% |
| 1 Year Change | 79.25% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 21.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 14.9% | -2.6% | -1.3% |
| 1Y | 79.2% | -0.7% | 4.2% |
Return vs Industry: 0HB exceeded the German Medical Equipment industry which returned -14.1% over the past year.
Return vs Market: 0HB exceeded the German Market which returned 5.9% over the past year.
Price Volatility
| 0HB volatility | |
|---|---|
| 0HB Average Weekly Movement | 15.5% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 9.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0HB's share price has been volatile over the past 3 months.
Volatility Over Time: 0HB's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 77 | Wensheng Fan | https://www.spectral-ai.com |
Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. It offers DeepView wound imaging solution, an AI technology and multispectral imaging system that provides healing assessments for burn wounds and diabetic foot ulcers. Spectral MD Holdings, Ltd.
Spectral AI, Inc. Fundamentals Summary
| 0HB fundamental statistics | |
|---|---|
| Market cap | €79.69m |
| Earnings (TTM) | -€5.58m |
| Revenue (TTM) | €22.91m |
3.4x
P/S Ratio-14.0x
P/E RatioIs 0HB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HB income statement (TTM) | |
|---|---|
| Revenue | US$24.60m |
| Cost of Revenue | US$13.97m |
| Gross Profit | US$10.63m |
| Other Expenses | US$16.62m |
| Earnings | -US$5.99m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.044 |
| Gross Margin | 43.20% |
| Net Profit Margin | -24.36% |
| Debt/Equity Ratio | 0.8% |
How did 0HB perform over the long term?
See historical performance and comparison